FibroGen (China) Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 160

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

FibroGen (China) General Information

Description

Operator of a biopharmaceutical technology company based in Beijing, China. The company has roxadustat capsule which is the world's first innovative drug based on the Nobel Prize-winning mechanism - hypoxia-inducible factor (HIF) and the breakthrough theory of oxygen sensing, enabling patients with anemia due to chronic kidney disease with effective innovative drugs.

Contact Information

Website
www.fibrogen.cn
Formerly Known As
Beijing FibroGen Pharmaceutical Technology Development Co., Ltd.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Building A2, Number 88
  • Kechuang 6th Street, Beijing Economic and Technological Development Zone
  • Beijing, 101111
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
AstraZeneca
Corporate Office
  • Building A2, Number 88
  • Kechuang 6th Street, Beijing Economic and Technological Development Zone
  • Beijing, 101111
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FibroGen (China) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore FibroGen (China)‘s full profile, request access.

Request a free trial

FibroGen (China) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical technology company based in Beijing, China. The company has roxadustat capsule which is
Drug Discovery
Beijing, China
160 As of 2019

San Francisco, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FibroGen (China) Competitors (27)

One of FibroGen (China)’s 27 competitors is Pliant Therapeutics, a Formerly VC-backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pliant Therapeutics Formerly VC-backed San Francisco, CA
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
viDA Therapeutics Venture Capital-Backed Vancouver, Canada
Enterprise Therapeutics Venture Capital-Backed Brighton, United Kingdom
BPS Bioscience Corporation San Diego, CA
You’re viewing 5 of 27 competitors. Get the full list »

FibroGen (China) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FibroGen (China) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore FibroGen (China)‘s full profile, request access.

Request a free trial

FibroGen (China) FAQs

  • When was FibroGen (China) founded?

    FibroGen (China) was founded in 2011.

  • Where is FibroGen (China) headquartered?

    FibroGen (China) is headquartered in Beijing, China.

  • What is the size of FibroGen (China)?

    FibroGen (China) has 160 total employees.

  • What industry is FibroGen (China) in?

    FibroGen (China)’s primary industry is Drug Discovery.

  • Is FibroGen (China) a private or public company?

    FibroGen (China) is a Private company.

  • What is the current valuation of FibroGen (China)?

    The current valuation of FibroGen (China) is .

  • What is FibroGen (China)’s current revenue?

    The current revenue for FibroGen (China) is .

  • Who are FibroGen (China)’s investors?

    Kyntra Bio has invested in FibroGen (China).

  • Who are FibroGen (China)’s competitors?

    Pliant Therapeutics, Sarepta Therapeutics, viDA Therapeutics, Enterprise Therapeutics, and BPS Bioscience are some of the 27 competitors of FibroGen (China).

  • When was FibroGen (China) acquired?

    FibroGen (China) was acquired on 29-Aug-2025.

  • Who acquired FibroGen (China)?

    FibroGen (China) was acquired by AstraZeneca.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process